Cancer test kit HERIGUARD™ BRCA

oncologyfor genetic testingfor BRCA mutations

Hereditary cancers account for ~5% of all malignancies and occur because of an inherited deleterious gene alteration from one of the parents. People carrying such alterations have a high risk of developing cancer at an early age, as well as developing multiple synchronous or metachronous cancers. Genetic screening of high-risk populations, such as individuals with a family history of cancer, is important in identifying cancer-related germline genetic variants and the chance of developing cancer in your lifetime, prompting early discovery of cancer lesions and improving patient survival. It also reveals genetic mutations that could be passed down to your children and their likelihood of getting cancer. A comprehensive test for detecting germline alterations in 30 genes including BRCA1/2 genes  Heriguard™ BRCA detects germline single nucleotide variants (SNVs), insertions and deletions (indels), copy number variations (CNVs), and large genomic rearrangements (LGR) of 30 susceptible genes of breast and gynecologic cancers, including BRCA1/BRCA2 genes. By gaining early awareness of such mutations, it could effectively prevent the occurrence of cancer or achieve early diagnosis/treatment through routine screening. WHO IS IT FOR High risk population of breast and gynecologic cancers Healthy individuals seeking to understand their cancer risk